Marie Alt

1.2k citations

20 papers · 748 indexed · 1 hit paper · h-index 11

Impact in

Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
Otorhinolaryngology top 5%
- Head and Neck Cancer Studies

Papers in

Cancer Research 9
- Cancer Genomics and Diagnostics 9
Oncology 10
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 3

Co-authors: Christophe Le Tourneau Xavier Paolettí Vincent Servois Delphine Loirat Esma Saâda-Bouzid Jocelyn Gal J. Guigay Frédéric Peyrade
Journals: Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)JNCI Journal of the National Cancer Institute (1 paper)Investigational New Drugs (1 paper)Seminars in Oncology (1 paper)
Partner nations: France Canada United States

In The Last Decade

Marie Alt

18 papers receiving 737 citations

Hit Papers

align trajectories log scale

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma 2017 · 449 citations

Peers

Countries citing papers authored by Marie Alt

Since Specialization

Citations

This map shows the geographic impact of Marie Alt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Alt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Alt more than expected).

Fields of papers citing papers by Marie Alt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Alt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Alt. The network helps show where Marie Alt may publish in the future.

Co-authors

The 25 scholars most cited alongside Marie Alt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marie Alt Line = papers co-authored together Marie Alt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma BMC Cancer ·Marie Alt, Mitchell H Neal, Yi‐An Lin, Gbenga Kazeem, Erik T. Goluboff, Srikala S. Sridhar	2023	1
2	Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC) Seminars in Oncology ·Mitchell H Neal, Marie Alt, Di Jiang, Harry Ralph, Nazanin Fallah‐Rad, Sharlene Gill, Mary Elliot, Srikala S. Sridhar	2022	1
3	Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature Oncology and Therapy ·Mitchell H Neal, Marie Alt, Di Jiang, Peter Chung, Juanita Crook, Girish S. Kulkarni, Srikala S. Sridhar	2021	17
4	Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma Investigational New Drugs ·Grégoire Marret, Nicolás Isambert, Keyvan Rezaï, Jocelyn Gal, Esma Saâda-Bouzid, Frédéric Rolland, P. Maragos, Édith Borcoman, Marie Alt, Jerzy Klijanienko, Damien Vansteene, J. Guigay, Maud Kamal, Ivan Bièche, Christophe Le Tourneau, (unknown)	2021	18
5	Enfortumab Vedotin in urothelial cancer Therapeutic Advances in Urology ·Marie Alt, Mitchell H Neal, Maribel Rodríguez, Di Jiang, Srikala S. Sridhar	2020	30
6	Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians Cancer Treatment Reviews ·Rajshree Kadam, Marie Alt, Christophe Le Tourneau, Jérémy Augustin, Chloé Broudin, Viviane Mukim de Moraes, Thomas Denize, H. Mirghani, Elizabeth Fabre, Madeleine Ménard, Florian Scotté, Éric Tartour, Cécile Badoual	2018	46
7	Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma Annals of Oncology ·Esma Saâda-Bouzid, Немирович Ольга Васильевна, Andy Karabajakian, Virginia Palomar Coloma, Vincent Servois, Xavier Paolettí, Caroline Even, Jérôme Fayette, J. Guigay, Delphine Loirat, Frédéric Peyrade, Marie Alt, Jocelyn Gal, Christophe Le Tourneau Hit paper breakdown →	2017	449
8	SHIVA: Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer—Overall survival (OS) analysis. Journal of Clinical Oncology ·Sylvain Dureau, Francesco Ricci, Marie Alt, Delphine Loirat, Marie‐Paule Sablin, Maud Kamal, Ivan Bièche, Sébastien Armanet, Jean‐Pierre Delord, Anthony Gonçalvès, Céline Gavoille, Coraline Dubot, Nicolás Isambert, Mario Campone, Olivier Trédan, Aya Takayama, Aurélien Latouche, Lisa Belin, Christophe Le Tourneau	2017	4
9	Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial Annals of Oncology ·Lisa Belin, Maud Kamal, Nihat Özçelik, Corine Plancher, Sehar Ajmal, Jean‐Pierre Delord, Anthony Gonçalvès, Céline Gavoille, Coraline Dubot, Nicolás Isambert, Mario Campone, Olivier Trédan, Francesco Ricci, Marie Alt, Delphine Loirat, 勝子日高, Xavier Paolettí, Vincent Servois, Mateus Armando	2016	44
10	SHIVA: Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer—PFS ratio from patients who crossed-over. Journal of Clinical Oncology ·Christophe Le Tourneau, Maud Kamal, Nihat Özçelik, Sehar Ajmal, Jean‐Pierre Delord, Anthony Gonçalvès, Céline Gavoille, Coraline Dubot, Nicolás Isambert, Mario Campone, Olivier Trédan, Francesco Ricci, Marie Alt, Delphine Loirat, Marie‐Paule Sablin, Xavier Paolettí, Vincent Servois, Lisa Belin	2016	2
11	Designs of preoperative biomarkers trials in oncology: a systematic review of the literature Annals of Oncology ·Aya Takayama, Ivan Bièche, Xavier Paolettí, Marie Alt, A.R. Abdul Razak, Anastasios Stathis, 炜嵇, Christophe Le Tourneau	2015	12
12	Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials JNCI Journal of the National Cancer Institute ·Christophe Le Tourneau, Maud Kamal, Apostolia M. Tsimberidou, Philippe L. Bédard, Gaëlle Pierron, Céline Callens, Étienne Rouleau, Anne Vincent‐Salomon, Nicolas Servant, Marie Alt, Roman Rouzier, Xavier Paolettí, Olivier Delattre, Ivan Bièche	2015	56
13	First-in-human study of LY3039478, a Notch signaling inhibitor in advanced or metastatic cancer. Journal of Clinical Oncology ·Christophe Massard, Analía Azaro, Christophe Le Tourneau, Jean‐Charles Soria, Marie Alt, Claire Smith, U. Ohnmacht, Luthieska Aparecida Santos Garcia, W.I Sánchez, Eunice Yuen, Karim A. Benhadji, Jordi Rodón	2015	3
14	A randomized, open-label, Phase II trial evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with advanced solid tumors. Journal of Clinical Oncology ·Maud Toulmonde, Christophe Le Tourneau, Antoîne Italiano, 中路貴紀, Isabelle Laure Ray-Coquard, Claire Cropet, Aude Fléchon, Françoise Desseigne, Marie Alt, Christelle de la Fouchardière, Jérôme Fayette, Édith Borcoman, Pierre-Étienne Heudel, Nuriyah Inda Kurniah, Bonn SPD-Parteivorstand, David Pérol, Jean‐Yves Blay	2015	0
15	La réunion de concertation pluridisciplinaire moléculaire de l’Institut Curie Maud Kamal, Marie Alt, Gaëlle Pierron, Céline Callens, Étienne Rouleau, Samia Melaabi, Odette Mariani, Vincent Servois, Nathalie Clément, Anne Vincent‐Salomon, José Ramón Crettaz, Ivan Bièche, Christophe Le Tourneau	2015	3
16	The spectrum of clinical trials aiming at personalizing medicine. PubMed ·Christophe Le Tourneau, Maud Kamal, Marie Alt, Loïc Verlingue, Vincent Servois, Marie‐Paule Sablin, Nicolas Servant, Xavier Paolettí	2014	18
17	Challenges for the Implementation of High-Throughput Testing and Liquid Biopsies in Personalized Medicine Cancer Trials Personalized Medicine ·Loïc Verlingue, Marie Alt, Maud Kamal, Marie‐Paule Sablin, Mustapha Zoubir, Sayuri Shimizu, Jean‐Yves Pierga, Nicolas Servant, Xavier Paolettí, Christophe Le Tourneau	2014	7
18	Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? Bulletin du Cancer ·Marie Vanhuyse, Nicolas Penel, Armelle Caty, I. Fumagalli, Marie Alt, Laurent Zini, Antoine Adenis	2012	10
19	Brain metastasis in metastatic renal cell carcinoma: Predictive factors of occurrence and survival with or without antiangiogenic therapy. Journal of Clinical Oncology ·Marie Vanhuyse, Nicolas Penel, Armelle Caty, I. Fumagalli, Marie Alt, Luca Zini, Antoine Adenis	2011	0
20	Contrast-Enhanced Power and Color Doppler Ultrasonography of the Pancreas in Healthy and Diseased Cats Journal of Veterinary Internal Medicine ·Nathalie Rademacher, Stefanie Ohlerth, G. Scharf, T. J. Homec, Nadja S. Sieber‐Ruckstuhl, Marie Alt, Małgorzata Roos, Paula Grest, Barbara Kaser‐Hotz	2008	27

About Marie Alt

Marie Alt is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 748 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Renal cell carcinoma treatment (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Oncology (543 citations), Otorhinolaryngology (82 citations), Cancer Research (160 citations), Pulmonary and Respiratory Medicine (256 citations) and Immunology (148 citations). Marie Alt has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Christophe Le Tourneau, Xavier Paolettí, Vincent Servois, Delphine Loirat, Esma Saâda-Bouzid, Jocelyn Gal, J. Guigay, Frédéric Peyrade, Virginia Palomar Coloma and Caroline Even. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, JNCI Journal of the National Cancer Institute, Investigational New Drugs and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact